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Primary sarcomas of the mediastinum are rare, and data concerning
treatment and results of therapy are sparse. Objective: To assess presenta-
tion, management, prognostic factors, and survival in mediastinal sarco-
mas. Methods: We reviewed our experience with 47 patients with the
diagnosis of primary sarcoma of the mediastinum. Data were collected from
a computerized institutional database and medical records. Survival was
analyzed by Kaplan-Meier method and comparisons of survival by log rank
test. Results: The median age of 47 patients with mediastinal sarcoma was
39 years (range 2.5 to 69 years), with a male/female ratio of 1.6. The most
common complaints were chest/shoulder pain (38%) and dyspnea (23%).
The most common tumor types were malignant peripheral nerve tumor
(26%), spindle cell sarcoma (15%), leiomyosarcoma (9%), and liposarcoma
(9%). Operation was the primary treatment modality in 72% of cases (n 5
34); 22 sarcomas (47%) were completely resected. The overall 5-year
survival was 32%. High-grade lesions had a significantly decreased survival
(5-year survival 5 27%) compared with low-grade tumors (5-year sur-
vival 5 66%) (p 5 0.05). The overwhelming factor determining survival was
the ability to completely resect the tumors (5-year survival 49% for
complete resection; 3-year survival 18% for incomplete or no resection)
(p 5 0.0016). Despite complete resection, local recurrence occurred in 64%
of cases. Conclusion: Because the overall survival for patients with medias-
tinal sarcomas is 32% and the local recurrence is 64% for tumors
completely resected, aggressive adjuvant therapy should continue to be
systematically explored. (J Thorac Cardiovasc Surg 1998;115:671-80)
Sarcomas originating in the mediastinum are rare,and the literature has primarily reflected anec-
dotal case reports. No consistent approach in the
diagnosis and management of these tumors has been
described. Like sarcomas originating in the retro-
peritoneum, most cases have presented as large
tumors close to vital structures, making manage-
ment difficult. Because of the paucity of information
on presentation, treatment, and outcome in patients
with primary sarcomas of the mediastinum, we
reviewed our experience at Memorial Sloan-Ketter-
ing Cancer Center.
Materials and methods
A computerized search of the medical records at our
institution from January 1, 1940, to December 31, 1991,
yielded charts of 47 patients with primary mediastinal
sarcoma. Primary mediastinal sarcoma was defined as a
sarcoma arising in the anatomic space between the two
pleurae of the chest. The anterior mediastinum included
the area bounded by the undersurface of the sternum and
the anterior surfaces of the great vessels. The middle
mediastinum, which is also known as the visceral compart-
ment, was depicted as the area bounded anteriorly by the
anterior compartment and extending to the anterior lon-
gitudinal spinal ligament; it included sarcomas surround-
ing the pericardium, trachea, and main bronchi and
surrounding or originating from the heart. The posterior
mediastinum was defined as the costovertebral region or
paravertebral sulci.1 Seventy-nine percent of the patients
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(37 of 47) had tissue available for review, and the slides
were reexamined by one pathologist (S.I.H.), who classi-
fied tumors as low or high grade on the basis of cellular
differentiation, degree of tumor cellularity and vascularity,
amount of necrosis, and the number of mitoses per 10
high-power microscopic fields.2, 3 We performed a de-
tailed retrospective review of the medical records with
emphasis on pertinent past medical history, presentation,
diagnostic evaluation, histology, treatment, and outcome.
We defined local recurrence as the new appearance of
sarcoma in the site of definitive therapy. Metastases were
defined as sarcoma distinctly removed from the site of the
primary tumor. Actuarial survival was calculated by the
Kaplan-Meier method and differences in survival were
determined by log-rank analysis.4
Results
Clinical presentation. Of the 47 patients who
were seen at Memorial Sloan-Kettering Cancer
Center with a diagnosis of mediastinal sarcoma, 29
were male and 18 were female (ratio 1.6 to 1). The
median age was 39 years (range 2.5 to 69 years).
Three patients were 11 years old or younger; exclud-
ing these three, the median age was 41 years (range
18 to 69 years).
Six patients (13%) had a history of radiation
therapy 6 to 21 years before diagnosis of mediastinal
sarcoma. One patient had a mediastinal liposarcoma
develop 16 years after radiation therapy for retino-
blastoma. Three patients received mantle radiation
for Hodgkin’s disease; two had malignant peripheral
nerve tumors, and one had an unclassified high-
grade sarcoma. Two received mediastinal radiation
for non-Hodgkin’s lymphoma; one had a spindle cell
sarcoma, the other a rhabdomyosarcoma. Three
patients had von Recklinghausen’s disease. Two of
these had malignant peripheral nerve tumors and
one a high-grade leiomyosarcoma.
Forty-two patients had a documented period of
symptoms, the median of which was 4 months;
ranging from 0 to 16 months. Presenting complaints
included chest or shoulder pain in 18 patients
(38%), dyspnea in 11 patients (23%), cough in 4
patients (9%), paresthesias in 4 patients (9%), he-
moptysis in 3 patients (6%), fever of undetermined
origin in 3 patients (6%), and hoarseness in 2
patients (4%).
Bilateral upper extremity thrombophlebitis, Hor-
ner’s syndrome, and acute myocardial infarction were
seen in one patient each. Weight loss was noted in nine
patients (19%). In these patients the average reported
weight loss was 15 pounds (Table I).
Method of diagnosis. The presence of a medias-
tinal tumor was most often documented by chest
x-ray film. Twenty-five patients had only a chest
x-ray film without other diagnostic studies before
undergoing exploratory thoracotomy. In more re-
cent years computerized tomography (13 patients)
and magnetic resonance imaging (six patients) have
been used in addition to plain chest films.
Of the 41 patients who had the location of the
primary tumor recorded, 17 (41%) were noted to be
in the anterior mediastinal compartment and 20
(49%) were in the posterior mediastinum. Four
patients (10%) had middle mediastinal sarcomas,
including two originating from the heart (Fig. 1).
Clinical size of the lesions was recorded in 21
patients, and ranged from 4 to 20 cm, with a median
of 10 cm. The estimated clinical size of the sarcomas
correlated closely with the pathologic specimen
measurements.
Histology and grade. The histology and grade of
the 47 primary sarcomas of the mediastinum are
listed in Table II. The most common types of
sarcoma in this series were malignant peripheral
nerve tumor (MPNT) (n 5 12, 26%), spindle cell
sarcoma (n 5 7, 15%), leiomyosarcoma (n 5 5,
11%), embryonal rhabdomyosarcoma (n 5 4, 9%),
and liposarcoma (n 5 4, 9%). Of the tumors able to
be graded, 25 patients (68%) had high-grade and 12
patients (32%) had low-grade tumors; 10 patients
(21%) had insufficient material for grading by our
reviewing pathologist. Of the 12 MPNTs, 4 were
noted to be high grade, 5 were low grade, and 3 were
ungraded. Of the undifferentiated spindle cell sar-
comas, three were high grade, one was low grade,
and three were not graded. All five leiomyosarcomas
Table I. Primary sarcoma of the mediastinum:
Clinical presentation
n %
Complaints
Chest/shoulder pain 18 38
Dyspnea 11 23
Cough 4 9
Paresthesias 4 9
Hemoptysis 3 6
Fever of unknown origin 3 6
Hoarseness 2 4
Bilateral arm phlebitis 1 2
Horner’s syndrome 1 2
Acute myocardial infarction 1 2
Weight loss 9 19
Past history
Previous radiation to chest 5 11
von Recklinghausen’s disease 3 9
Retinoblastoma 1 2
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and both malignant fibrous histiocytomas were high-
grade tumors. The embryonal rhabdomyosarcomas
were noted to be high grade in three, and one was
ungraded. The remaining sarcomas were equally
divided between high and low grades. Four (18%) of
the 22 completely resected tumors were noted to
have associated lymph node involvement: two spin-
dle cell sarcomas, one embryonal rhabdomyosar-
coma, and one angiosarcoma.
Treatment approaches. Operation was the pri-
mary treatment modality in 72% of patients (34 of
47). Fifteen patients received radiation therapy in
addition to the operation. Thirteen patients re-
ceived chemotherapy either before or after opera-
tion, and six patients received chemotherapy, radi-
ation, and resection. Eleven patients received
chemotherapy and radiation as primary treatment
for their tumors. Two patients elected no treatment
Fig. 1. Location of the primary mediastinal sarcoma was recorded in 41 patients. Seventeen were located
in the anterior compartment, 4 in the middle compartment, and 20 in the posterior compartment.
Table II. Primary sarcoma of the mediastinum: Histologic findings and grade
n %
High
grade
(n)
Low
grade
(n)
Ungraded
(n)
Malignant peripheral nerve tumor 12 26 4 5 3
Spindle cell sarcoma 7 15 3 1 3
Leiomyosarcoma 5 11 5 0 0
Embryonal rhabdomyosarcoma 4 9 3 0 1
Liposarcoma 4 9 2 2 0
Fibrosarcoma 3 6 2 1 0
Malignant fibrous histiocytoma 2 4 2 0 0
Angiosarcoma 2 4 0 1 1
Rhabdomyosarcoma 2 4 1 0 1
Unclassified 2 4 1 1 0
Chondrosarcoma 1 2 0 0 1
Hemangiopericytoma 1 2 0 1 0
Osteosarcoma (extraosseus) 1 2 1 0 0
Synovial sarcoma 1 2 1 0 0
Totals 47 100 25 12 10
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after tissue diagnosis (Table III). Of the 30 patients
who received chemotherapy, 7 received it preoper-
atively as “induction” chemotherapy. Most of the
chemotherapy regimens included doxorubicin, cy-
clophosphamide, and/or cisplatin. Nitrogen mustard
and ifosfamide were used infrequently. Four pa-
tients received primary brachytherapy (intraopera-
tive radiation implants) for suspected or grossly
positive resection margins.
Complications of operation. Of the 34 patients who
underwent an operative approach to their tumors, 12
(35%) had more than one major procedure to treat
the primary tumor or recurrence. Five patients under-
went three operations, three patients had four opera-
tions, and one patient had five operations. Significant
complications occurred in 12 patients (21%) after a
total of 56 operations. These included three patients
with pulmonary emboli within 48 hours of operation,
upper extremity phlebitis in two, and four cases of
pulmonary infection and sepsis. Solitary cases of
Brown-Se´quard syndrome, major upper gastrointesti-
nal bleeding, and right hand paralysis attest to the
gravity of these complications.
Four patients (12%) died after operation, two
after a complete and two after an incomplete resec-
tion. Twenty-two of the 34 patients (65%) undergo-
ing operation had a complete resection of the
tumor. To achieve a complete resection, common
structures resected included chest wall, pericardium,
superior vena cava, vertebra, lung, and diaphragm.
Local recurrence. Of the 47 patients with medi-
astinal sarcoma, 34 underwent operation, 22 had
complete resection, and 12 an incomplete resection.
Four of the incompletely resected tumors were
believed to have been grossly resected at the time of
operation but were later found to have positive
margins and were classified as incompletely resected
tumors without persistent disease. Fourteen of the
22 completely resected tumors (64%) recurred lo-
cally. Half of the recurrences developed after resec-
tion of high-grade lesions (Table IV). Three (14%)
of these patients received preoperative radiation,
and seven (33%) had postoperative radiation ther-
apy. Ten patients received chemotherapy, including
two who had both preoperative and postoperative
chemotherapy. Seven of the patients having com-
plete resections with local recurrences underwent
chemotherapy and radiation.
Histologically, the most common tumor to recur
locally after complete resection was MPNT, which
accounted for 50% of the recurrences in this group
(7 of 14). Two of the local recurrences were in
liposarcomas, and two occurred after resection of
leiomyosarcomas. The remaining locally recurring
tumors were single cases of rhabdomyosarcoma,
angiosarcoma, and synovial sarcoma (Table V).
Metastases. Twenty patients (43%) in this series
had metastases develop (Table IV). Sixteen had
metastases early during various treatments, and four
additional patients eventually were diagnosed with
metastatic disease subsequent to primary therapy.
Of the 22 completely resected tumors, 7 (32%)
patients had metastases develop, including three
patients who also had local recurrence. Eleven of
the patients with metastatic disease had high-grade
lesions (55%), two had low-grade lesions, and seven
had ungraded tumors. Metastases developed in 11
of the 25 high-grade tumors (44%). Metastases
developed in 2 of the 12 low-grade lesions (17%).
Four of five patients with leiomyosarcoma had me-
Table III. Primary sarcoma of the mediastinum:
Treatment approaches in 47 patients
Primary therapy No.
None 2
Surgery only 0
Surgery and radiation therapy 15
Surgery and chemotherapy 13
Surgery, radiation therapy, and chemotherapy 6
Radiation therapy and chemotherapy 11
Table IV. Primary sarcoma of the mediastinum:
Tumor recurrence
n Local recurrence Metastases
Completely resected 22 14 (64%) 7 (32%)
Incompletely or not
resected
25 — 13 (52%)
14: 7 high grade
6 low grade
1 ungraded
20: 11 high grade
2 low grade
7 ungraded
Table V. Number of local and distal recurrences in
the more common mediastinal sarcomas
Sarcoma n
Local
recurrence Metastases
Malignant peripheral nerve tumor 12 7 4
Spindle cell sarcoma 7 0 3
Leiomyosarcoma 5 2 4
Embryonal rhabdomyosarcoma 4 1 3
Liposarcoma 4 2 0
Fibrosarcoma 3 0 1
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tastases develop (80%). Four of 12 patients (33%)
with MPNT also had metastases develop, as well as
three of four (75%) with embryonal rhabdomyosar-
comas, and three of seven (43%) with spindle cell
sarcoma eventually had metastases develop (Table
V).
Twelve patients had solitary organ metastases
only, and eight had multiple organ involvement. The
most common site of metastasis was the lung (6 of
20, 30%), followed by liver and bone, each with 5
instances (25%). Three patients had brain metasta-
ses (15%). The subcutaneous tissues and chest wall
regions each had two (10%). Seven of the patients
who had metastases received no therapy for their
systemic recurrence. Four patients had only chemo-
therapy and three had only radiation therapy. Two
received combination chemotherapy and radiation.
Three patients had operations for their metastatic
disease and one was operated on in conjunction with
radiation and chemotherapy.
Disease-free interval. Of the 22 patients who
underwent complete resection of their lesions, 14
had local recurrence (64%) during or after treat-
ment. Local recurrence occurred in less than 1
month in one patient. Median time to local recur-
rence was 11 months (range 2 weeks to 132 months).
In the seven patients who experienced subsequent
metastases after complete resection (including three
who also had local recurrence), the median time to
diagnosis of distant disease was 14 months (range 2
weeks to 25 months). Of the 12 patients with
low-grade tumors, median survival was 3 months
after diagnosis of recurrent disease, which was also
the median survival in the 25 patients with high-
grade tumors after recurrent disease was diagnosed.
Survival. Median follow-up time in this series of
47 patients was 14 months. Median survival was 13
months. Overall survival was 32% at 5 years (Fig. 2).
Patients with high-grade lesions had a significantly
decreased survival compared with patients with low-
grade lesions (p 5 0.05) (Fig. 3). The 5-year survival
for patients with high-grade lesions was 27%, and
the 5-year survival for the 12 patients with low-grade
tumors was 66%. Twenty-two patients had complete
resection of their sarcomas and had a significantly
prolonged survival compared with the 25 patients
who had incomplete or no resection (p 5 0.0016)
(Fig. 4). The 5-year survival in patients who under-
went complete resection was 49%; the 3-year sur-
vival in the incompletely or not resected group was
only 18%. Grade did not have a significant impact
on survival if patients had complete resection (p 5
0.12) (Fig. 5). Local recurrence did not gave an
impact on survival in the patients who underwent
complete resection, although the number of patients
who did not experience local recurrence was small
(n 5 8). No difference in survival was found in
patients with tumors greater than 10 cm compared
Fig. 2. Overall survival in 47 patients with primary mediastinal sarcoma. Overall actuarial survival was
32% at 5 years.
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with those with tumors smaller than 10 cm, although
a trend (p 5 0.08) is evident from Fig. 6. We
evaluated the influence of age on survival and found
no difference in survival in patients less than 39
years old compared with the patients older than 39.
We examined survival according to histologic find-
ings; however, the number of patients in the differ-
ent subgroups was too small to allow meaningful
analysis. The 12 patients with MPNT histologic
findings were noted to have a 5-year survival rate of
Fig. 3. Overall actuarial survival stratified by tumor grade. Patients with high-grade tumors had a 5-year
survival of 27% compared with the 5-year survival of 66% in those with low-grade lesions.
Fig. 4. Actuarial survival curves stratified by completeness of tumor resection demonstrate that those who
had complete tumor resection had a 49% 5-year survival compared with an 18% 5-year survival in those
patients who had incomplete or no resection.
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36%, whereas no patient with the other more com-
mon sarcomas survived more than 2 years after
diagnosis. The impact of the different modalities of
treatment was also difficult to analyze because of the
wide diversity in treatment approaches. However, it
was noted that seven patients completed “induc-
tion” chemotherapy before operative resection of
their tumors, and four (all high-grade lesions)
Fig. 5. Overall actuarial survival in patients who had complete resection stratified by grade. In those
patients who had complete resection of their sarcomas, tumor grade did not have an impact on survival.
Fig. 6. Overall actuarial survival stratified by size in the 21 patients where size had been recorded. The
median and mean tumor size was 10 cm. Survival in patients with sarcomas larger than 10 cm was not
significantly different than those with smaller lesions, although a trend is apparent.
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achieved complete tumor resection, two of whom
also received radiation therapy.
Discussion
Primary sarcomas of the mediastinum are rare.
Patients with mediastinal sarcomas have a discour-
agingly poor prognosis despite a multidisciplinary
approach. Patients may have ominous signs and/or
symptoms because of the location of these lesions. It
is also the location of these tumors adjacent to vital
structures that makes their management difficult.
No consistent approach to the management of pa-
tients with primary mediastinal sarcomas has been
delineated in the past because of sparse data, as well
as the discouraging attempt to control the disease in
a hazardous region.
In an attempt to analyze treatment approaches,
we retrospectively reviewed clinical presentation,
histologic findings, grade, treatment, and outcome
in 47 patients who were seen at our institution with
a primary mediastinal sarcoma over the past four
decades. Because of the rarity of this tumor, our
series represents one of the largest. A German
series included 22 patients with sarcomas of the
mediastinum in 1982, but this series was noted to
contain carcinosarcomas, “lymphatic sarcomas,”
and “round cellular sarcomas,” and probably do not
represent true sarcomas as currently defined.5 To
place the incidence of these tumors in perspective,
most adolescent and adult mediastinal tumors are
benign. Forty percent of mediastinal masses prove
to be malignant.6 Six percent to 7% of mediastinal
tumors represent mesenchymal neoplasms, and half
of these are considered malignant.7 In addition, of
the neurogenic tumors of the mediastinum, only
10% to 20% are estimated to be malignant.6, 7
A total of 3419 soft tissue sarcomas of all sites was
seen at our institution over the past 40 years; our 47
patients with primary mediastinal sarcoma repre-
sented 1.4% of these. Because approximately 6000
sarcomas are seen in the United States yearly, it is
estimated that 84 patients per year will have a
primary mediastinal sarcoma.
In reviewing clinical presentation of mediastinal
sarcomas, we found that most patients are symptom-
atic. Only five patients (11%) were asymptomatic
and were discovered to have a tumor by incidental
chest films. It has been recognized that only 10% of
malignant mediastinal neoplasms are asymptomatic;
90% of lesions that occur in asymptomatic patients
are benign.7 The symptoms could be described as
nonspecific (chest pain, fever of undetermined ori-
gin, weight loss) or caused by compression or inva-
sion of surrounding structures (dyspnea, cough,
dysphagia, Horner’s syndrome, hoarseness, pares-
thesia, hemoptysis). Hypoglycemia as a paraneo-
plastic syndrome has been described in advanced
fibrosarcoma, neurofibrosarcoma, and hemangio-
pericytoma.8, 9 Pertinent history in a patient with a
mediastinal sarcoma includes a history of von Reck-
linghausen’s disease with its propensity to malignant
degeneration of neurofibromas.10 Four patients
(8.5%) in our series had this history, of which three
had MPNT develop; interestingly, the fourth patient
had a leiomyosarcoma.
A history of previous radiation exposure has been
recognized as a predisposing factor in the develop-
ment of sarcomas.11-15 In our series three patients
had mantle radiation therapy for Hodgkin’s disease
and two for non-Hodgkin’s lymphoma. One patient
was irradiated for retinoblastoma. Although radia-
tion-induced sarcomas are more commonly malig-
nant fibrous histiocytomas, none in our series was of
this subtype: two were MPNTs, one was a spindle
cell sarcoma, one a rhabdomyosarcoma, and one
was unclassified. Literature describing radiation-
induced sarcomas in the mediastinum is sparse.
Most reported cases of sarcoma arising in the field
of radiation for Hodgkin’s disease or breast cancer
are not noted in the mediastinum but rather in the
clavicle, scapula, humerus, or subscapular fossa.11, 14
Sporadic cases in the mediastinum have been re-
ported.12, 13
As expected, most sarcomas occurred in the pos-
terior mediastinum (49%), and the most common
tumor was MPNT. Nine of 12 (75%) MPNTs oc-
curred in the posterior mediastinum, reflecting the
location of major peripheral nerves in the paraver-
tebral sulci. Most authorities have confirmed that
the most common tumor in the posterior mediasti-
num is neurogenic. When tumor is confined to one
hemithorax, an intercostal nerve origin is suspected,
whereas if the tumor crosses the midline, sympa-
thetic nerve origin is most likely.16
The discovery of a mediastinal mass was most
often by chest x-ray film in our study. Plain chest
films, other than defining the presence of a mass, are
not particularly helpful, although the presence of
calcification may lead one to suspect chondrosar-
coma, osteogenic sarcoma, teratoma, or thymo-
ma.17-19 Recently, magnetic resonance imaging has
been used to define thoracic malignancies. Magnetic
resonance imaging can accurately delineate vascular
structures without the use of contrast material and
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seems to better define soft tissue tumors from
adjacent normal tissues such as the spinal cord and
bone.15, 20, 21 One case report in the literature of a
leiomyosarcoma of the superior vena cava was noted
to be poorly demarcated by computed tomography
and plain chest films; however, the magnetic reso-
nance imaging scan proved useful in defining the
location and extent of this tumor.13
Tissue obtained by fine-needle aspiration biopsy
has been described in the diagnosis of mediastinal
seminomas, embryonal carcinomas, carcinoids, and
neuroendocrine tumors; however, the usefulness of
this technique in the primary diagnosis of sarcomas
has not been confirmed, and none of our patients
had diagnostic confirmation by this method.22
Despite an aggressive operative approach, as well
as the use of radiation therapy and/or chemother-
apy, the local recurrence rate in patients having a
complete resection proved high (64%), and sur-
passed the incidence of distant metastasis (43%).
High grade did not contribute toward a higher local
recurrence rate. This is in contradistinction to re-
currence rates reported for retroperitoneal and vis-
ceral sarcomas.23 Authorities have agreed that loca-
tion may prove most important in the frequency of
local recurrence in mediastinal sarcomas rather than
histologic subtype24 and probably reflects the inabil-
ity to obtain wide margins during resection. Once
recurrence has occurred, survival is short (with a
median survival of 3 months), despite aggressive
resection of recurrences and the use of radiation
and chemotherapy. Because of the high incidence of
local recurrence of these sarcomas despite complete
resection, aggressive adjuvant therapy should con-
tinue to be explored.
The grade of primary mediastinal sarcomas had
made a significant impact on survival, with high-
grade lesions having a poorer prognosis than low-
grade lesions (27% 5-year survival for high-grade vs
66% 5-year survival for low-grade lesions). How-
ever, the factor most predictive of survival was
complete resection, and the survival in those com-
pletely resected was not influenced by tumor grade.
In addition, other factors, such as location and size,
must be taken into account. One interesting, but
small, subgroup of patients who qualified for com-
plete resection was noted in the seven cases who
underwent preoperative chemotherapy. Of these
seven, four were completely resected (including two
who received adjuvant radiation as well in the form
of brachytherapy or postoperative radiation). All
four were high-grade tumors. Two patients remain
disease-free 13 and 28 months later; two are alive
with disease 6 and 66 months later. Because com-
plete resection is the most important prognostic
factor determining survival in our series, “induc-
tion” chemotherapy may prove to be an important
approach.
Survival of patients with soft tissue sarcoma of the
chest wall was found to be comparable to that of
patients with sarcomas of the extremities.25 This
may reflect the ability to detect and resect these
readily accessible lesions early. Mediastinal sarco-
mas elude early detection and appear to be similar
to retroperitoneal tumors in this respect. Two large
series on retroperitoneal sarcomas have also shown
that the ability to completely resect these lesions was
the most important prognostic factor. The use of
radiation therapy and chemotherapy, age, and size
did not affect survival, which is similar to the results
we describe in this series of mediastinal sarcomas.
Unlike our series, grade of the retroperitoneal tu-
mor influenced the survival of patients who had
undergone complete resection.26, 27
Although no consistent approach was used in the
management of these tumors, most cases involved
multidisciplinary treatments. Despite this, primary
sarcomas of the mediastinum have a poor prognosis.
The most significant factor having an impact on
survival in this series was the ability to completely
resect the primary mediastinal sarcoma.
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